These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8628338

  • 1. Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis.
    Bishai WR, Graham NM, Harrington S, Page C, Moore-Rice K, Hooper N, Chaisson RE.
    N Engl J Med; 1996 Jun 13; 334(24):1573-6. PubMed ID: 8628338
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pyrosequencing-based approach for rapid detection of rifampin-resistant Mycobacterium tuberculosis.
    Zhao JR, Bai YJ, Zhang QH, Wang Y, Luo M, Yan XJ.
    Diagn Microbiol Infect Dis; 2005 Feb 13; 51(2):135-7. PubMed ID: 15698720
    [Abstract] [Full Text] [Related]

  • 9. Molecular analysis of rifampin-resistant Mycobacterium tuberculosis isolated from Korea by polymerase chain reaction-single strand conformation polymorphism sequence analysis.
    Lee H, Cho SN, Bang HE, Lee JH, Bae GH, Kim SJ, Kim JD.
    Int J Tuberc Lung Dis; 1998 Jul 13; 2(7):585-9. PubMed ID: 9661827
    [Abstract] [Full Text] [Related]

  • 10. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis.
    Zhao JR, Bai YJ, Wang Y, Zhang QH, Luo M, Yan XJ.
    Int J Tuberc Lung Dis; 2005 Mar 13; 9(3):328-32. PubMed ID: 15786899
    [Abstract] [Full Text] [Related]

  • 11. Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis.
    March F, Garriga X, Rodríguez P, Moreno C, Garrigó M, Coll P, Prats G.
    Clin Infect Dis; 1997 Nov 13; 25(5):1044-7. PubMed ID: 9402354
    [Abstract] [Full Text] [Related]

  • 12. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.
    Soudani A, Hadjfredj S, Zribi M, Masmoudi A, Messaoud T, Tiouri H, Fendri C.
    J Clin Microbiol; 2007 Sep 13; 45(9):3095-7. PubMed ID: 17652484
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection.
    Small PM, Shafer RW, Hopewell PC, Singh SP, Murphy MJ, Desmond E, Sierra MF, Schoolnik GK.
    N Engl J Med; 1993 Apr 22; 328(16):1137-44. PubMed ID: 8096066
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of the CombiChip Mycobacteria Drug-Resistance detection DNA chip for identifying mutations associated with resistance to isoniazid and rifampin in Mycobacterium tuberculosis.
    Kim SY, Park YJ, Song E, Jang H, Kim C, Yoo J, Kang SJ.
    Diagn Microbiol Infect Dis; 2006 Mar 22; 54(3):203-10. PubMed ID: 16458476
    [Abstract] [Full Text] [Related]

  • 18. rpoB mutations as an epidemiologic marker in rifampin-resistant Mycobacterium tuberculosis.
    Chaves F, Alonso-Sanz M, Rebollo MJ, Tercero JC, Jimenez MS, Noriega AR.
    Int J Tuberc Lung Dis; 2000 Aug 22; 4(8):765-70. PubMed ID: 10949329
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.